Topical Corticosteroid Selection for Contact Dermatitis
For contact dermatitis in adults, use mid- to high-potency topical corticosteroids such as triamcinolone 0.1% or clobetasol 0.05% for localized lesions, applied once or twice daily for up to 3 weeks. 1
Potency Selection Based on Location and Severity
The choice of topical corticosteroid depends critically on the anatomic location and extent of involvement:
For Localized Contact Dermatitis
- Mid-potency (Class 4-5): Triamcinolone 0.1% is appropriate for most body areas
- High-potency (Class 1-2): Clobetasol 0.05% for thick, chronic plaques or areas requiring more aggressive treatment 1
Location-Specific Considerations
Critical caveat: Never use high-potency steroids on the face, intertriginous areas, or thin skin regions due to high risk of atrophy, striae, and telangiectasias 2, 3. For facial involvement:
- Use low-potency corticosteroids only (Class 6-7)
- Consider clocortolone pivalate 0.1% cream (Class 4) as a mid-potency option that has demonstrated safety on facial skin 4
- Limit duration to minimize adverse effects
Treatment Duration and Application
Standard regimen:
- Apply once or twice daily
- Continue for up to 3 weeks for super-high-potency agents 3
- Up to 12 weeks for high- or medium-potency formulations 3
- No time limit exists for low-potency agents
Important: Topical corticosteroids should be applied to affected areas only, not prophylactically to unaffected skin 2.
Extensive Disease Requiring Systemic Therapy
When contact dermatitis involves >20% body surface area, systemic corticosteroids become necessary 1:
- Oral prednisone provides relief within 12-24 hours
- Must taper over 2-3 weeks to prevent rebound dermatitis
- Rapid discontinuation causes disease flare 1
This is particularly relevant for severe rhus (poison ivy) dermatitis where inadequate steroid courses lead to recurrence.
Formulation Selection
Match the vehicle to the clinical presentation:
- Ointments: Best for dry, lichenified lesions (most occlusive, highest potency delivery)
- Creams: Versatile for most presentations
- Lotions/solutions: For hairy areas or weeping lesions
- Gels/foams: For scalp involvement 3
Common Pitfalls to Avoid
Underdosing: Use fingertip unit method—one fingertip unit covers approximately 2% body surface area 3
Wrong potency for location: High-potency steroids on face/intertriginous areas cause irreversible atrophy and telangiectasias 2
Inadequate systemic course: Short oral steroid courses (<2 weeks) for extensive disease cause rebound 1
Continuing steroids without identifying allergen: If treatment fails, patch testing is mandatory to identify the specific allergen for avoidance 2, 5
Adjunctive Measures
While topical corticosteroids are the primary treatment 2:
- Emollients and soap substitutes are essential adjuncts
- Barrier protection (gloves) prevents re-exposure
- After-work creams reduce recurrence risk 2
The evidence strongly supports topical corticosteroids as first-line therapy, with the specific agent chosen based on anatomic location being the most critical decision point to balance efficacy against the risk of adverse effects.